Sold as Durabolin. Every FDA application for this active ingredient: 1 branded and 4 generic.
As of Nov 15, 2026, FDA lists 5 applications for Nandrolone Phenpropionate (sold as Durabolin), first approved Oct 30, 1959, with 0 new uses approved and 0 published complete response letters.
| Impact of Medically Supervised Performance-Enhancing Substances (PES) on Elite AthletesSafety and Impact of Medically Supervised Performance Enhancing Substance Usage in Healthy Elite Athletes · Enhanced Emirates Limited | Not applicable | Enrolling by invitation | May 6, 2026 |
| Peri-Operative Testosterone Administration in Primary Total Hip ArthroplastyOsteoarthritis, Hip · American Hip Institute | Phase 4 | Not yet recruiting | Sep 23, 2024 |
| Peri-Operative Testosterone Administration in Primary Hip ArthroscopyFemoro Acetabular Impingement · American Hip Institute | Phase 4 | Not yet recruiting | Jun 17, 2024 |
| Study of the Effectiveness of Treatment of Sarcopenia With the Use of a Medicinal Product (Nandrolone), Comprehensive Physiotherapy and DietSarcopenia · National Institute of Geriatrics, Rheumatology and Rehabilitation, Poland | Phase 2 | Recruiting | Aug 7, 2023 |
| Oct 30, 1959 | DurabolinNDA 11891 · New molecular entity | Organon USA Inc | 6 | Discontinued |
| — | Nandrolone PhenpropionateANDA 86386 | Watson Labs | 0 | Discontinued |
| — | Nandrolone PhenpropionateANDA 87488 | Watson Labs | 0 | Discontinued |
| — | Nandrolone PhenpropionateANDA 89297 | Quad Pharms | 0 | Discontinued |
| — | Nandrolone PhenpropionateANDA 89298 | Quad Pharms | 0 | Discontinued |
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient. Drugs@FDA
